Morphic Holding, Inc.
MORFNASDAQHealthcare
$56.99
+$0.02(+0.04%)
Market Cap$2.9B
P/E Ratio—
52W High$57.0
52W Low$19.345
Morphic Holding, Inc. (MORF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MORF · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2024Report Date: Jul 25, 2024EPS Actual
-$1.15
Est. -$0.96 · -19.8%
Revenue
—
Est. $0.00B
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Jul 25, 2024
After Market Close
▼ Miss EPS
MORF reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Jul 25, 2024 | -$0.96 | -$1.15 | -19.8% | — | $0.00B | — |
| ▲ Q2 FY2024 | Apr 25, 2024 | -$0.96 | -$0.91 | +5.2% | — | — | — |
| ▼ Q1 FY2024 | Feb 22, 2024 | -$0.89 | -$0.94 | -5.6% | $-0.06B | — | — |
| ▲ Q4 FY2023 | Nov 3, 2023 | -$0.98 | -$0.73 | +25.5% | — | $0.00B | — |
| ▼ Q3 FY2023 | Aug 3, 2023 | -$0.90 | -$0.92 | -2.2% | $0.06B | $0.00B | +5923.6% |
| ▼ Q2 FY2023 | Apr 25, 2023 | -$0.85 | -$0.90 | -5.9% | $0.00B | $0.00B | -61.1% |
| ▲ Q1 FY2023 | Feb 23, 2023 | -$0.85 | -$0.64 | +24.7% | $0.01B | $0.00B | +101.8% |
| ▲ Q4 FY2022 | Nov 2, 2022 | -$0.80 | -$0.78 | +2.5% | $0.00B | $0.00B | -41.0% |
Q3 FY2024
Jul 25, 2024Miss
EPS Actual
-$1.15
EPS Est.
-$0.96
EPS Surpr.
-19.8%
Revenue
—
Q2 FY2024
Apr 25, 2024Beat
EPS Actual
-$0.91
EPS Est.
-$0.96
EPS Surpr.
+5.2%
Revenue
—
Q1 FY2024
Feb 22, 2024Miss
EPS Actual
-$0.94
EPS Est.
-$0.89
EPS Surpr.
-5.6%
Revenue
$-0.06B
Q4 FY2023
Nov 3, 2023Beat
EPS Actual
-$0.73
EPS Est.
-$0.98
EPS Surpr.
+25.5%
Revenue
—
Q3 FY2023
Aug 3, 2023Miss
EPS Actual
-$0.92
EPS Est.
-$0.90
EPS Surpr.
-2.2%
Revenue
$0.06B
Q2 FY2023
Apr 25, 2023Miss
EPS Actual
-$0.90
EPS Est.
-$0.85
EPS Surpr.
-5.9%
Revenue
$0.00B
Q1 FY2023
Feb 23, 2023Beat
EPS Actual
-$0.64
EPS Est.
-$0.85
EPS Surpr.
+24.7%
Revenue
$0.01B
Q4 FY2022
Nov 2, 2022Beat
EPS Actual
-$0.78
EPS Est.
-$0.80
EPS Surpr.
+2.5%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $-1.14 | $-1.01 | $-0.86 | 2 |
| Q3 FY2024 | $-1.05 | $-0.94 | $-0.81 | 2 |
| Q2 FY2024 | $-1.15 | $-1.00 | $-0.88 | 9 |
| Q1 FY2024 | $-0.94 | $-0.94 | $-0.94 | 4 |
| Q4 FY2023 | $-1.07 | $-0.86 | $-0.72 | 9 |
| Q3 FY2023 | $-0.95 | $-0.95 | $-0.95 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 18 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 8 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Jul 25, 2024 | -19.8% | $56.55 | $56.61 | +0.11% |
| ▲ Q2 FY2024 | Apr 25, 2024 | +5.2% | $27.69 | $27.98 | +1.05% |
| ▼ Q1 FY2024 | Feb 22, 2024 | -5.6% | $35.48 | $35.85 | +1.04% |
| ▲ Q4 FY2023 | Nov 3, 2023 | +25.5% | $20.86 | $22.57 | +8.20% |
| ▼ Q3 FY2023 | Aug 3, 2023 | -2.2% | $58.69 | $57.59 | -1.87% |
| ▼ Q2 FY2023 | Apr 25, 2023 | -5.9% | $43.53 | $46.70 | +7.28% |
| ▲ Q1 FY2023 | Feb 23, 2023 | +24.7% | $42.16 | $42.98 | +1.94% |
| ▲ Q4 FY2022 | Nov 2, 2022 | +2.5% | $29.47 | $28.12 | -4.58% |
Q3 FY2024+0.11%
Report Date
Jul 25, 2024
EPS Beat/Miss
-19.8%
Price Before
$56.55
Price After
$56.61
Q2 FY2024+1.05%
Report Date
Apr 25, 2024
EPS Beat/Miss
+5.2%
Price Before
$27.69
Price After
$27.98
Q1 FY2024+1.04%
Report Date
Feb 22, 2024
EPS Beat/Miss
-5.6%
Price Before
$35.48
Price After
$35.85
Q4 FY2023+8.20%
Report Date
Nov 3, 2023
EPS Beat/Miss
+25.5%
Price Before
$20.86
Price After
$22.57
Q3 FY2023-1.87%
Report Date
Aug 3, 2023
EPS Beat/Miss
-2.2%
Price Before
$58.69
Price After
$57.59
Q2 FY2023+7.28%
Report Date
Apr 25, 2023
EPS Beat/Miss
-5.9%
Price Before
$43.53
Price After
$46.70
Q1 FY2023+1.94%
Report Date
Feb 23, 2023
EPS Beat/Miss
+24.7%
Price Before
$42.16
Price After
$42.98
Q4 FY2022-4.58%
Report Date
Nov 2, 2022
EPS Beat/Miss
+2.5%
Price Before
$29.47
Price After
$28.12
Avg Beat Reaction+1.65%
Avg Miss Reaction+1.64%
Beat Rate4 / 8 quarters
Largest Move+8.20% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MORF ends December
Morphic Holding, Inc. (MORF) most recently reported earnings on July 25, 2024 for Q3 FY2024, posting EPS of $-1.15 — missing the analyst consensus of $-0.96 by -19.8%. The next MORF earnings date is expected around September 1, 2026.
Each quarter, investors track MORF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MORF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MORF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MORF earnings · 5 questionsMorphic Holding, Inc.'s next earnings report is expected around September 1, 2026. MORF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MORF historically reports after market close (AMC).
MORF earnings datewhen is MORF earningsMORF next earnings datewhen does MORF report earningsMORF earnings calendar
▸ Source: FMP · Morphic Holding, Inc. SEC filings · US GAAP · Morphic Holding, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026